Skip to main content
NCBI home page
Molecular Cancer logoLink to Molecular Cancer
. 2021 Aug 17;20:102. doi: 10.1186/s12943-021-01391-x

Correction to: Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance

Tao Zhang 1,#, Rong Qu 1,#, Shingpan Chan 2,#, Mengzhen Lai 1,3, Linjiang Tong 1, Fang Feng 1, Hongyu Chen 4, Tingting Song 4, Peiran Song 1, Gang Bai 1,5,6, Yingqiang Liu 1,3, Yanan Wang 1, Yan Li 1, Yi Su 1, Yanyan Shen 1, Yiming Sun 1, Yi Chen 1, Meiyu Geng 1, Ke Ding 2,✉, Jian Ding 1,✉, Hua Xie 1,✉
PMCID: PMC8369743  PMID: 34404402

Correction to: Mol Cancer 19, 90 (2020)

https://doi.org/10.1186/s12943-020-01202-9

Following the publication of the original paper [1], the authors found minor typographical errors that should be corrected.

In the Results section, the dosage of ASK120067 in the sentence “we present a preliminary result of a patient in this clinical study with a confirmed radiographic response after treatment with the lowest dose (40 mg/kg once daily)” has been corrected to “…with the lowest dose (40 mg once daily)”.

In the figure legend of Figure 3g, the sentence “Computed tomography scans of the chest from a patient before and after treatment with 40 mg/kg ASK120067 in a phase I trial…” has been corrected to “…treatment with 40 mg ASK120067 once daily in a phase I trial…”.

These corrections have no impact on the results or conclusions of the study.

The original article has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Tao Zhang, Rong Qu, and Shingpan Chan contributed equally to this work.

Contributor Information

Ke Ding, Email: dingke@jnu.edu.cn.

Jian Ding, Email: jding@simm.ac.cn.

Hua Xie, Email: hxie@simm.ac.cn.

Reference

  • 1.Zhang T, Qu R, Chan S, et al. Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance. Mol Cancer. 2020;19:90. doi: 10.1186/s12943-020-01202-9. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Molecular Cancer are provided here courtesy of BMC

RESOURCES